Latanoprost for glaucoma: primum non nocere - Authors' reply

Affiliations

¹ National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK. Electronic address: david.garway-heath@moorfields.nhs.uk.
² National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
³ Norfolk and Norwich University Hospital, Norfolk, UK.
⁴ Addenbrooke's Hospital, Cambridge, UK.

Comment

David F Garway-Heath et al. Lancet. 2015.

. 2015 Aug 15;386(9994):652.

doi: 10.1016/S0140-6736(15)61500-8.

¹ National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK. Electronic address: david.garway-heath@moorfields.nhs.uk.
² National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
³ Norfolk and Norwich University Hospital, Norfolk, UK.
⁴ Addenbrooke's Hospital, Cambridge, UK.

No abstract available

Comment on

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG. Garway-Heath DF, et al. Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19. Lancet. 2015. PMID: 25533656 Clinical Trial.
Latanoprost for glaucoma: primum non nocere.
Wegner A. Wegner A. Lancet. 2015 Aug 15;386(9994):651-2. doi: 10.1016/S0140-6736(15)61499-4. Lancet. 2015. PMID: 26334155 No abstract available.